FGFR3 and neoplasm: SYTL1 was significantly down-regulated in the T2–4 (FGFR3-non-mutated) tumor group whereas LEPRE1, MICAL2, RAB23 and STXBP1 were significantly up-regulated in the same tumor group (Table 4 and Figure 7; see summary in Figure 2).